We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
87 hedge funds and large institutions have $64M invested in Invesco Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
1.71% less ownership
Funds ownership: 23.1% → 21.39% (-1.7%)
7% less funds holding
Funds holding: 94 → 87 (-7)
16% less capital invested
Capital invested by funds: $75.9M → $64M (-$11.9M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
58% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 31
Holders
87
Holders Change
-7
Holders Change %
-7.45%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
13
Reduced
31
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$673K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$445K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$425K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$383K |
